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The effects of adding methylprednisolone to low-potassium
dextran solution on preserved ischemic lungs
Ali YEGİNSU1, Makbule ERGİN1, Hüseyin ÖZYURT2, Çiğdem ELMAS3, Güleser ÇAĞLAR GÖKTAŞ3

Aim: To investigate the effects of adding methylprednisolone to low-potassium dextran solution on cold-preserved
ischemic lungs.
Materials and methods: The study included 42 rat lung blocks that were divided into 7 groups (n = 6). Lung blocks were
preserved in 40 mL of cold Perfadex solution, to which 5, 15, 30, 60, and 120 mg kg−1 (approximately 40, 120, 240, 480,
and 960 mg L−1) of methylprednisolone were added. After a 24-h preservation period, the lungs were removed from the
solution and examined.
Results: As compared to the Perfadex only group, cell death and degeneration were significantly higher in the Perfadex
+ methylprednisolone groups (P < 0.05). MDA and IL-8 levels were higher in all Perfadex + methylprednisolone groups.
Statistically significant differences were observed between some of these groups. Antioxidant enzyme activity was
generally higher in the Perfadex + methylprednisolone groups than in the Perfadex only group (P < 0.05).
Conclusion: Adding methylprednisolone to low-potassium dextran solution does not have any beneficial effects but has
possible deleterious effects in rat lung preservation.
Key words: Lung transplantation, organ preservation, Perfadex, methylprednisolone, rat

Düşük potasyumlu dekstran solusyonuna metilprednizolon ilavesinin iskemik
akciğer koruma üzerine etkileri
Amaç: Bu çalışmanın amacı düşük potasyumlu dekstran solusyonuna metilprednizolon ilavesinin iskemik akciğer
koruma üzerine etkilerini araştırmaktı.
Yöntem ve gereç: Kırk iki verici sıçan akciğer bloğu 7 gruba bölündü (n = 6). Akciğer blokları 40 mL 5, 15, 30, 60 ve 120
mg kg−1 (yaklaşık 40, 120, 240, 480 ve 960 mg L−1) soğuk Perfadex solusyonu içerisinde korundu. Yirmi dört saatlik
koruma süresi sonrasında akciğerler solusyondan çıkarıldı ve tetkikler için saklandı.
Bulgular: Metilprednizolon eklenmiş Perfadex grubunda hücre ölümü ve dejenerasyon Perfadex grubuna kıyasla anlamlı
olarak daha fazlaydı (P < 0,05). MDA ve İL-8 düzeyleri metilprednizolon eklenen tüm gruplarda daha yüksekti. Bu
grupların bazılarında istatistiksel anlamlılık vardı. Antioksidan enzim aktiviteleri metilprednizolon eklenmiş Perfadex
gruplarında Perfadex gruplarına kıyasla genel olarak daha yüksekti (P < 0,05).
Sonuç: Düşük potasyumlu dekstran solusyonuna eklenen metilprednizolonun sıçanlarda akciğer korumada yararlı bir
etkisi olmamakla birlikte, muhtemel zararlı etkileri mevcuttur.
Anahtar sözcükler: Akciğer nakli, organ koruma, perfadex, metilprednizolon, sıçan
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Introduction
To date, lung transplantation remains the best
therapeutic option for end-stage lung disease. One of
the main determinants in obtaining successful lung
transplantation results is optimal preservation of the
donor lung and use of the optimal preservation
solution. Low-potassium dextran solution (Perfadex)
has been commonly used in lung transplantation at
many institutions, and the superiority of Perfadex to
other preservation solutions used in lung
transplantation has been reported (1).
In clinical application some additives have been
used together with organ preservation solutions, such
as steroids (2), prostaglandin E1 (3), raffinose (4), and
pH-regulating drugs (5), for improving the
preservative effect. Glucocorticoids are one of the
most potent anti-inflammatory agents known to
clinical medicine. Pharmacologic doses of
glucocorticoids dramatically inhibit exudation of
plasma and accumulation of leukocytes at sites of
inflammation. They antagonize macrophage
differentiation, inhibit neutrophil adhesion to
endothelial cells, decrease circulating eosinophil and
basophil counts, and decrease the accumulation of
eosinophils and mast cells at sites of allergic reactions.
They have profound effects on the activation and
subsequent function of endothelial cells, and clearly
inhibit vascular permeability (6).
The purpose of the present study was to investigate
the dose-dependent effects of methylprednisolone
(MP) added to Perfadex solution on lung
preservation.
Materials and methods
Animals
The study included 42 male Wistar rats weighing
280-320 g. This study was approved by the local ethics
committee and was funded by the scientific research
board of our university. All animals received humane
care in compliance with the “Guide for the Care and
Use of Laboratory Animals,” prepared by the Institute
of Laboratory Animal Resources (7).
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Agents
Perfadex solution (Vitrolife, Sweden), for
experimental use only, was obtained from Vitrolife
and methylprednisolone (Prednol-L, Mustafa Nevzat,
Türkiye) was commercially obtained.
Surgical procedure
The rats were divided into 7 groups (n = 6). After
−1
anesthesia with 30 mg kg of IV thiopentone (pental
sodium, IE Ulagay, İstanbul, Turkey), the rats were
intubated via tracheostomy and connected to a rodent
ventilator (Harvard Inspira ASVV, MA, USA).
Animals were ventilated with room air, 4-cm H2O
positive end-expiratory pressure, and at 60 breaths
min−1. Heparin 50 IU was given through the penile
vein and 5 min later laparo-sternotomy was
performed. The inferior vena cava, and right and left
atrial appendages were cut. The lungs were flushed
with 20 mL of 1-4 °C Perfadex or Perfadex + MP
solutions through the pulmonary artery with a
pressure of 20-cm H2O. In controls, lungs were
removed immediately after flushing with isotonic
saline. In the Perfadex + MP groups, 5, 15, 30, 60, and
120 mg kg−1 (approximately 40, 120, 240, 480, and 960
mg L−1, respectively) of MP were added to Perfadex
solution. After flushing, the trachea was tied and the
lungs were inflated. The lung-heart block was
removed and immersed in 40 mL of Perfadex or
Perfadex + MP solutions at 1-4 °C. After a 24-h
preservation period the lung blocks were removed
from the solutions. Left lungs were used for the
determination of cell death; the right upper lobes were
kept in 10% formalin solution for morphometric
studies and the remaining lobes were kept at −80 °C
for biochemical studies.
Histological assessment of cell death
Lungs were flushed for 5 min with 20 mL of 500
mmol L−1 Trypan blue (Sigma Chemical) solution
through the main pulmonary artery. This flush was
followed by 20 mL of 0.9% normal saline solution.
Trypan blue was dissolved in Krebs-Henseleit buffer
(pH 7.4; Sigma Chemical). The lungs were then fixed
in 10% formalin. The middle third of each left lung
was used for histological examination, as it is
representative of the peripheral and central
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parenchymal areas. An eosin counterstain was used
to identify all viable cells, which do not pick up
Trypan blue as dead cells do because they lose their
ability to exclude the dye actively. Cells were counted
from 10 randomly chosen fields per slide. All viable
cells were counted first, followed by all Trypan bluestained cells. Results for dead cells are expressed as a
percentage of total cells.
Morphometric study
All tissues were transferred immediately to 10%
formalin for 72 h, dehydrated in graded alcohols, and
embedded in paraffin wax. Sections 4-μm thick were
cut on a microtome (Leica SM 2000, Germany).
Afterwards, the slides were counterstained with
hematoxylin-eosin. All slides were evaluated using a
Leica photomicroscope and camera (DM 4000 B, and
DFC280 Plus Camera, Leica, Weetlar, Germany). Ten
histopathologic evaluations per field were made, and
10 fields in each section were analyzed. Infiltration,
terminal bronchial wall damage and debris,
respiratory bronchial wall damage and debris, and
alveolar degeneration were evaluated. Each was
graded as follows: 1: absent; 2: mild; 3: moderate; 4:
severe. Mean scores were recorded for each rat.
Preparation of lung tissue homogenate
Lung tissue was stored at –80 °C until analyzed.
After weighing the lung tissues, homogenization in 5
volumes of ice-cold tris-HCl buffer (50 mM, pH 7.4)
−1
containing 0.50 mL L of Triton X-100 was
performed for 2 min at 13,000 rpm (homogenizer:
IKA Ultra-Turrax T 25 Basic, Germany). All
procedures were performed at 4 °C. The homogenate,
supernatant, and extracted samples were prepared,
and then the samples were analyzed using commercial
chemicals supplied by Sigma (St Louis, MO, USA).
Protein measurements of the samples were taken as
described by Lowry et al. (8).
Biochemical analysis
Determination
of
interleukin-8
level,
antioxidant enzyme activity, and lipid peroxidation
IL-8 levels were measured using the enzymelinked immunosorbent assay (ELISA). IL-8 levels are

expressed as pg mL−1. Total (Cu-Zn and Mn) SOD
(EC 1.15.1.1) activity was determined according to the
method of Sun et al. (9). SOD activity is expressed as
-1
U mg of protein. Glutathione peroxidase (GPX)
activity was measured according to Paglia and
-1
Valentine (10) and is expressed as U g of protein.
The malondialdehyde (MDA) level, which
indicates lipid peroxidation, was determined using a
method based on reaction with thiobarbituric acid
(TBA) at 90-100 °C (11). Results are expressed as
-1
nmol g of wet tissue, according to the standard
graphic prepared from measurements with a standard
solution (1,1,3,3-tetramethoxypropane).
Statistics
SPSS v.15.0 was used for statistical evaluation. Data
are expressed as mean ± SD. The Kruskal-Wallis test
was used for comparisons between the groups. Post
hoc multiple comparisons were calculated with the
Mann-Whitney U test. P values < 0.05 were
considered significant.
Results
The Perfadex and Perfadex + MP groups had more
inflammation and cell damage than the control group.
In the Perfadex + MP groups the percentage of cell
death and severity of degeneration were significantly
higher than in the Perfadex only group. IL-8 levels
were higher in all the Perfadex + MP groups than in
the Perfadex only group, and statistically significant
differences were observed between the Perfadex only
group, and the MP15, MP30, and MP60 groups. MDA
levels were also higher in the Perfadex + MP groups
than in the Perfadex only group, and the difference
between the MP120 group and the Perfadex only
group was significant (P < 0.05). SOD activity was
lower in the MP5 and MP15 groups than in the
Perfadex only group; however, the differences were
not significant. The MP30 and MP120 groups had
significantly higher SOD activity than the Perfadex
only group. The difference in GPX activity between
the groups was not statistically significant. The results
of the statistical analysis of the groups are shown in
Tables 1 and 2.
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Table 1. Evaluation of the study data. The Kruskal-Wallis test was used to compare the groups.
Parameter

Control

Perfa-dex

MP5

MP15

MP30

MP60

MP120

P

Cell death (%)

2.4 ± 0.5

33 ± 5

45 ± 5

46 ± 4

42 ± 5

41 ± 2

48 ± 3

<0.001*

Degeneration

1.1 ± 0.4

1.3 ± 0.5

2.5 ± 0.5

3.5 ± 0.5

3.3 ± 0.1

2.5 ± 0.8

2.6 ± 0.5

<0.001*

IL-8

49 ± 19

63 ± 20

76 ± 14

98 ± 19

100 ± 23

93 ± 16

81 ± 31

0.002*

MDA

1.62 ± 0.1

1.76 ± 0.3

2.38 ± 0.5

2.06 ± 0.1

2.04 ± 0.2

2.10 ± 0.6

2.47 ± 0.3

0.041*

SOD

50.3 ± 9

77.6 ± 9

73.2 ± 15

63.0 ± 15

136.84 ± 14

138.0 ± 15

90.2 ± 14

<0.001*

GPX

16.3 ± 1.8

23.0 6.6

23.8 ± 5.9

23.1 ± 8.8

23.1 ± 4.9

19.3 ± 2.7

23.6 ± 7.0

0.034*

*Statistically significant.
IL-8: Interleukin-8 (pg mL−1); MDA: malondialdehyde (nmol g−1 of wet tissue); SOD: superoxide dismutase
(U g−1 of protein); GPX: glutathione peroxidase (U g−1 of protein).

Table 2. Multiple comparisons of the groups (P values).
Groups

Cell Death

Degeneration

IL-8

MDA

SOD

GPX

Control-Perfadex

<0.001*

0.699

0.093

0.589

0.002*

0.132

Control-MP5

<0.001*

0.004*

0.026*

0.015*

0.004*

0.002*

Control-MP15

<0.001*

0.002*

0.004*

0.004*

0.009*

0.180

Control-MP30

<0.001*

0.026*

0.009*

0.015*

0.002*

0.015*

Control-MP60

<0.001*

0.026*

0.009*

0.093

0.002*

0.065

Control-MP120

<0.001*

0.004*

0.041*

0.004*

0.002*

0.065

Perfadex-MP5

<0.001*

0.015*

0.394

0.065

0.589

0.320

Perfadex-MP15

<0.001*

0.002*

0.026*

0.180

0.394

0.937

Prefadex-MP30

0.001*

0.004*

0.026*

0.180

0.002*

0.937

Perfadex-MP60

<0.001*

0.041*

0.026*

0.310

0.002*

0.394

Perfadex-MP120

<0.001*

0.009*

0.394

0.015*

0.589

1.000

MP5-MP15

0.796

0.026*

0.041*

0.240

0.937

0.485

MP5-MP30

0.123

0.180

0.065

0.394

0.002*

0.180

MP5-MP60

0.019*

0.818

0.093

0.699

0.002*

0.015*

MP5-MP120

0.218

0.699

0.818

0.699

0.394

0.699

MP15-MP30

0.063

0.699

0.818

0.932

0.002*

0.937

MP15-MP60

0.009*

0.065

0.818

0.818

0.002*

0.394

MP15-MP120

0.315

0.065

0.310

0.065

0.310

0.937

MP30-MP60

0.971

0.240

0.310

0.699

0.937

0.132

MP30-MP120

0.015*

0.310

0.310

0.041*

0.041*

0.699

MP60-MP120

0.001*

0.937

0.394

0.240

0.026*

0.093

*Statistically significant.
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Figure 1. Perfadex group. Increased lymphocyte infiltration (ß) was seen in the lung
tissue (AS). Regional alveolar ductal (AD) and respiratory bronchiolar (RB)
widening were noted (hematoxylin-eosin: 1A, 100× and 1B, 400×). Bv: blood
vessels, Al: alveolus, AS alveolar space.

Figure 2. MP-5 group. General structure of the lung tissue, predominantly alveoli (Al),
was degenerated. Terminal bronchiolar (TB) wall degeneration with infiltrative
cells and epithelial debris was seen. Alveoli were fused and composed very
large forms, and interalveolar connective tissue increased (hematoxylin-eosin:
2A, 100× and 2B, 400×).
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Figure 3. MP-120 group. Obvious lymphocyte infiltration (ß) and an increase in
connective tissue were noted, in general. Terminal bronchial (TB)
disarrangement and degeneration were present. Epithelial debris was seen in
the bronchiolar lumen. Alveolar (Al) wall was thickened site-by-site, and cells
were irregular. Macrophagic infiltration increased in the alveoli (hematoxylineosin: 3A, 40× and 3B, 400×).

Discussion
The present study shows that MP added to lung
preservation solution had some harmful effects on
lung tissue, such as increasing cell death and
degeneration, lipid peroxidation, IL-8 release, and
oxidative stress. To the best of our knowledge the
literature does not contain any reports that confirm
the present study’s results. In contrast to the present
study, those that used lazaroid U74500A, a type of
steroid-inhibiting lipid peroxidation, reported that
its addition enhanced the preservative effect of
University of Wisconsin solution (UWS) in
pulmonary grafts (12). It also protected lung grafts
from ischemia-reperfusion injury (13) and
improved endothelial cell viability (14). Hisatomi
−1
et al. (15) added 50, 100, 150, and 200 mg L of MP
to Euro-Collins solution in a myocardial
preservation study. Their results show that the
addition of the steroid to the preservation solution
might have been effective in preventing myocardial
injury during preservation of rat hearts, and the
optimal concentration appeared to range from 150
44

−1
to 200 mg L . Although it was not a lung
preservation study, its similarity to our study may
be of importance.

While systemic addition of MP to donor lungs
attenuated posttransplant graft function (16), our
study shows that addition of MP had some harmful
effects to donor lung tissue; however, it is not clear
why it was harmful. The commercial form of MP used
in the present study contained methylprednisolone
sodium succinate, sodium phosphate, sodium
chloride, lactose monohydrate, and distilled water; to
the best of our knowledge, the literature does contain
any reports about the direct toxic effects of these
chemicals on lung tissue.
It is known that the pH of preservation solution is
important for cell viability (17). The pH of MP is
about 7.20 and the addition of MP did not affect the
pH of Perfadex solution (pH value is about 5.8). We
measured the pH values of the Perfadex + MP
solutions (range: 5.8 to 6.1) and do not consider the
changes in pH values as the source of MP’s harmful
effects.
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Cellular electrophysiological changes might be a
cause of cell damage. As it is known, Na+/K+ -ATPase
pump function decreases in hypothermia (18).
Schramm et al. (19) reported that MP potentiated
Na+/K+ ATPase pump activity in rabbit airway smooth
muscle. As such, we can speculate that the cause of
cell damage was that MP altered ionic stability and
metabolic activity by potentiating Na+/K+ -ATPase
pump activity. We think additional studies are
necessary to evaluate our results more fully.
Cell viability was reported as a predictive factor in
posttransplant graft dysfunction (20). Transvascular
Trypan blue flush is a valuable technique for the
detection of dead cells in lungs. This technique has
been commonly used for lung and other tissues in
transplantation studies. Trypan blue staining easily
identifies all necrotic and apoptotic dead cells with
blue-stained nuclei. Fischer et al. (20) reported that,
whereas less than 3% of graft cells died in the early
period (first 12 h) of cold preservation, 27% of all cells
died by the 24th h of preservation. Additionally, they
reported that the percentage of necrotic cells was
inversely correlated to posttransplant graft
dysfunction. In the present study, the cell death rate
was 33% in the Perfadex only group versus 41%-48%
in the Perfadex + MP groups.
Fisher et al. (21) reported that IL-8 levels in donor
lungs were associated with early graft failure after lung
transplantation. Kaneda et al. (22) showed that
increased m-RNA expression in multiple cytokines in
donor lungs was associated with posttransplant
mortality. They reported that IL-6, IL-8, TNF-α, and
IL-1β were risk factors for mortality, and that IL-10
and IFN-c were protective factors.
Alveolar morphologic changes have been reported
after lung preservation (23). Severe alveolar
degeneration appeared after 24 h of storage.
Degenerative findings, such as lamellar degeneration
in type-II pneumocytes, type-I pneumocyte damage,
cytoplasmic vacuolization, contraction of the
endothelial lining of capillaries, vacuolization of
endothelial cells, and pericapillary edema may be seen
with light microscopy.

Antioxidant enzyme activity increased during
ischemic lung preservation (24). Superoxide
dismutase, which causes superoxide breakdown and
the subsequent production of hydrogen peroxide, has
a central role in the regulation of reactive oxygen
species (ROS) levels (25). Vascular smooth muscle
cells, pulmonary endothelial cells, and lung
macrophages generate superoxide under basal and
stimulated conditions (26). Glutathione peroxidase is
a cytosolic enzyme that also eliminates H2O2 and
includes a wide range of substrates (including lipid
peroxides). The primary function of glutathione
peroxidase is to detoxify low levels of H2O2 in cells
(27,28). In the present study the addition of MP to
preservation solution did not prevent an increase in
antioxidant enzyme activity.
Oxygen radicals react with polyunsaturated fatty
acid residues in phospholipids, and MDA is one of the
final products of that reaction in cells. An increase in
free radicals causes overproduction of MDA, the level
of which is a marker for oxidative stress (11,24). In
our previous study there was no statistically
significant increase in the MDA level, although
antioxidant enzyme activity increased. The present
study shows that the addition of MP to preservation
solution increased MDA levels.
The present study investigated the effects of MP
on preserved lung tissue, but not its posttransplant
effects, which is a limitation. We do not know how
these results would affect the posttransplant
condition. On the other hand, the findings in donor
lungs mentioned above may be helpful in predicting
transplantation outcomes; therefore, the present
results might indirectly indicate the posttransplant
course.
In conclusion, addition of MP to Perfadex solution
did not provide additional preservative benefits
during 24 h of cold preservation of ischemic rat lungs.
In contrast, the use of MP was associated with some
harmful effects on lung tissue, the mechanism of
which remains unknown. Further studies are needed
in order to collect more detailed data and for
clarifying the clinical use of MP.
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